NCT04096313View on ClinicalTrials.gov

Evaluation of the Analytical Performance of ALLEGRO™ Instrument

CompletedOBSERVATIONAL
Enrollment

628

Participants

Timeline

Start Date

March 25, 2020

Primary Completion Date

November 11, 2021

Study Completion Date

December 15, 2021

Conditions
Diabetes MellitusKidney DiseasesMetabolic Disease
Interventions
DIAGNOSTIC_TEST

HbA1c, Lipids, UACR

compare diagnostic tests to reference methods

Trial Locations (3)

33166

South Florida Research Organization, Medley

33458

Health Awareness, Inc, Jupiter

34952

Health Awareness, Inc PSL, Port Saint Lucie

Sponsors

Lead Sponsor

Nova Biomedical
All Listed Sponsors
lead

Nova Biomedical

INDUSTRY

NCT04096313 - Evaluation of the Analytical Performance of ALLEGRO™ Instrument | Biotech Hunter | Biotech Hunter